Take the Diabetes Health Pump Survey
See What's Inside
Read this FREE issue now
For healthcare professionals only
  • 12 Tips for Traveling With Diabetes
See the entire table of contents here!

You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View

See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.

Learn More About the Professional Subscription

Free Diabetes Health e-Newsletter
Latest
Popular
Top Rated
Diabetes Archives
Print | Email | Share | Comments (0)

Oral Insulin Being Tested — Insulin Sprayed Into Mouth

Jan 7, 2000

On May 10, Generex Biotechnology Corp. of Toronto announced it has commenced long-term, phase II clinical trials of its oral insulin. The trials will be conducted in people with type 1 and type 2 diabetes.

The trials will test the safety and efficacy of the oral insulin formulation for a minimum of six months. Specifically, these trials will involve the use of the oral insulin formulation to:

  1. replace mealtime insulin injections in insulin-dependent people with type 1 and type 2 diabetes
  2. replace failing tablet therapy in people with type 2 diabetes

Administered as a Spray into the Mouth

Generex's oral insulin is administered as a fine spray into the mouth via RapidMist-a small device that looks like an asthma inhaler.

According to Generex, there are currently 10 clinical sites in the United States, five sites in Canada and three sites in Europe participating in the long-term trials using the oral insulin formulation. Among these sites are The Diabetes and Glandular Disease Clinic of San Antonio, Texas and The National Research Institute of Los Angeles.

"We believe these long-term trials will demonstrate the positive benefits of oral insulin in helping type 1 and type 2 diabetics in achieving better control of this devastating disease," said Dr. Pankaj Modi, Generex's vice president of research. "Significantly, oral insulin will have an impact in the treatment of type 2 patients who are failing tablet therapy, since use of the oral insulin formulation will prevent the otherwise necessary insulin injection therapy."


Categories: Asthma, Diabetes, Diabetes, Insulin, Type 2 Issues



You May Also Be Interested In...


Click Here To View Or Post Comments

Comments 0 comments - Jan 7, 2000

©1991-2014 Diabetes Health | Home | Privacy | Press | Advertising | Help | Contact Us | Donate | Sitemap

Diabetes Health Medical Disclaimer

The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.